NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Active Not RecruitingNA

Sponsor: National Cancer Institute (NCI)

Conditions: Ovarian Carcinoma, Ovarian Germ Cell Tumor

Interventions: Laboratory Biomarker Analysis, Screening Questionnaire Administration, Ultrasound Imaging

Countries: United States

This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).

Eligibility overview

Sex: FEMALE

Age: 55 Years to 74 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Exclusion Criteria:

* Women who at the time of randomization are less than 55 or greater than or equal to 75 years of age
* Individuals undergoing treatment for cancer at this time, excluding basal-cell and squamous-cell skin cancer
* Individuals with known prior cancer of the colon, rectum, lung, or ovary

  * This includes primary or metastatic PLCO cancers
* Individuals with previous surgical removal of the entire colon or one lung

  * Until October 1996, women with previous surgical removal of both ovaries were excluded from the trial. In order to increase the enrollment of women into the trial, beginning in October 1996, these women were no longer excluded for this reason.
* Individuals who are participating in another cancer screening or cancer primary prevention trial
* Prior to April 1, 1999 women were excluded from the trial if they were currently taking or had taken Tamoxifen or Evista\\Raloxifene in the past 6 months. As of April 1999 based on a decision from the PLCO Ovary Subcommittee, women who have or are currently taking Tamoxifen or Evista\\Raloxifene are not excluded from participation.
* Individuals who are unwilling or unable to sign the informed consent form
* Individuals who have had a colonoscopy, sigmoidoscopy, or barium enema in the past three years

Locations (1)

Bethesda, Maryland, United States